Skip to main navigation Skip to search Skip to main content

The dexamethasone suppression test (1 mg and 2 mg) in major depression: Illness versus recovery

  • Gregory M. Asnis
  • , Uriel Halbreich
  • , Harry Rabinowitz
  • , Joaquim Puigh-Antich
  • , Hana Novacenko
  • Albert Einstein College of Medicine
  • Columbia University

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

This study reexamined the 1 mg and 2 mg DST in endogenous depression. Two groups of depressives were evaluated during illness and shortly after clinical recovery; one group with the 2 mg DST (N = 29) and another with the 1 mg DST (N = 16). The 2 mg DST was found to be a reliable state marker: all nonsuppressors during illness (N = 9) became suppressors after recovery. In contrast, the 1 mg DST was not a useful state marker: over 50% of the nonsuppressors during illness remained nonsuppressors after clinical recovery. A discussion of these discrepant findings dependent on the dose of dexamethasone is presented. This study suggests that although most psychiatric investigations are utilizing the 1 mg DST, the 2 mg DST should be reexamined.

Original languageEnglish
Pages (from-to)294-296
Number of pages3
JournalJournal of Clinical Psychopharmacology
Volume6
Issue number5
StatePublished - Oct 1986

Fingerprint

Dive into the research topics of 'The dexamethasone suppression test (1 mg and 2 mg) in major depression: Illness versus recovery'. Together they form a unique fingerprint.

Cite this